SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-199907
Filing Date
2023-08-01
Accepted
2023-08-01 07:10:52
Documents
17
Period of Report
2023-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d534121d8k.htm   iXBRL 8-K 78050
2 EX-2.1 d534121dex21.htm EX-2.1 681973
3 EX-10.1 d534121dex101.htm EX-10.1 58301
4 EX-10.2 d534121dex102.htm EX-10.2 31922
5 EX-99.1 d534121dex991.htm EX-99.1 56783
6 EX-99.2 d534121dex992.htm EX-99.2 37328
  Complete submission text file 0001193125-23-199907.txt   1288806

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rvmd-20230731.xsd EX-101.SCH 2885
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmd-20230731_lab.xml EX-101.LAB 17234
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmd-20230731_pre.xml EX-101.PRE 10835
11 EXTRACTED XBRL INSTANCE DOCUMENT d534121d8k_htm.xml XML 3233
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 231129632
SIC: 2836 Biological Products, (No Diagnostic Substances)